HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1678744Generated: October 30, 2026
alpha-Methyl-DL-leucine → 4-(3-Methyl-9-phenyl-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-8-yl)-benzylamine
https://huagongshe.com/reaction/1678744
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | alpha-Methyl-DL-leucine | HCID 95515 | — |
| Reactant | 4-(3-Methyl-9-phenyl[1,2,4]triazolo[3,4-f]-1,6-naphthyridin-8-yl)benzaldehyde | HCID 59472941 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | 4-(3-Methyl-9-phenyl-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-8-yl)-benzylamine | HCID 15979273 | — |
Reaction Steps
A suspension of 4-(3-methyl-9-phenyl[1,2,4]triazolo[3,4-f]-1,6-naphthyridin-8-yl)benzaldehyde (13, 0.25 g, 0.69 mmol) and 2-amino-2,4-dimethylpentanoic acid (3-7, 0.101 g, 0.69 mmol) in DMF (3 mL) was heated at 150° C. for 30 min. The reaction mixture cooled and the solvent was removed in vacuo. The crude residue was dissolved in 3N HCl (2.5 mL) and was heated at 100° C. for 30 min. The mixture was cooled and purified via reverse phase HPLC (5-65% acetonitrile/water over 15 min) to give, upon evaporation of the solvents, the title compound as a yellow solid. HRMS m/z (M+1) Calcd: 366.1713. Found 366.1715.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08008317B2 |
|---|
| Source dataset | uspto-grants-2011_08 |
|---|
| ORD ID | ord-fb4fe4861f764e7c8c41baa918afdfa4 |
|---|
| Source note | uspto-grants-2011_08 |
|---|